Harvest Portfolios Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$69.5M Sell
454,681
-37,333
-8% -$5.72M 1.15% 25
2025
Q4
$67.8M Buy
492,014
+6,684
+1% +$875K 1.18% 21
2025
Q3
$62.2M Sell
485,330
-7,238
-1% -$883K 1.15% 21
2025
Q2
$59.6M Sell
492,568
-11,070
-2% -$1.25M 1.39% 17
2025
Q1
$56.1M Sell
503,638
-26,702
-5% -$2.84M 1.66% 15
2024
Q4
$51.6M Buy
530,340
+32,077
+6% +$3.42M 1.72% 17
2024
Q3
$57.3M Sell
498,263
-19,676
-4% -$2.23M 1.9% 13
2024
Q2
$55.1M Buy
517,939
+32,968
+7% +$3.31M 2.11% 9
2024
Q1
$46.9M Sell
484,971
-36,361
-7% -$3.73M 1.83% 20
2023
Q4
$52.6M Buy
521,332
+3,715
+0.7% +$359K 2.23% 16
2023
Q3
$52.7M Buy
517,617
+28,079
+6% +$2.85M 2.49% 10
2023
Q2
$49.4M Sell
489,538
-56,051
-10% -$5.61M 2.27% 17
2023
Q1
$50.2M Buy
545,589
+28,460
+6% +$2.49M 2.46% 12
2022
Q4
$46.9M Buy
+517,129
New +$43.6M 2.7% 13

Other funds holding NVS

Harvest Portfolios Group's NVS Position: Q1 2026 in Review

Harvest Portfolios Group reduced its Novartis (NVS) stake by 7.6% in Q1 2026, selling an estimated $5.72M and leaving 454,681 shares worth $69.5M. The position accounts for 1.15% of the portfolio, ranked #25.

Harvest Portfolios Group first reported a position in NVS in Q4 2022 and has held it in 14 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Harvest Portfolios Group held 454,681 shares of Novartis worth $69.5M as of Q1 2026.
  • Harvest Portfolios Group sold 37,333 Novartis shares in Q1 2026, an estimated $5.72M.
  • Novartis made up 1.15% of Harvest Portfolios Group's portfolio in Q1 2026, its #25 holding.
  • Harvest Portfolios Group first reported a position in Novartis in Q4 2022 and has held it in 14 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Harvest Portfolios Group's 13F filing for Q1 2026, filed 14 May 2026.